4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001468308-26-000028
CHIEF FINANCIAL OFFICER sold 75,000 shares at $11.78 ($883,500)
- CHIEF FINANCIAL OFFICER acquired 21,928 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Andrade Robert · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-27 | Sale : show line 1 in the form 10b5-1 | −75,000 | $11.78 | $883,500 | 217,675 | D |
| 2026-08-28 | Exercise or conversion : show line 2 in the form 10b5-1 | +21,928 | $5.10 | $111,833 | 239,603 | D |
| Open-market sales · 75,000 sh · avg $11.78 · $883,500 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-28 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Options | −21,928 | 779,330 | D |
Loading xslF345X06/form4-08282026_090813.xml…